PSNY Earnings

PSNY reported its earnings on 2026-04-17, showcasing a revenue of against an estimate of 2.98B, resulting in a 0% surprise. The EPS was -2.36, surpassing the expected -13.42 by 82.41%. The stock experienced a -11.9% price change on the earnings day and a -11.66% change over the next five days, reflecting market reactions to the results.

Following PSNY's earnings announcement on 2026-04-17, the stock price moved by -11.9% on the day of the release. Over the subsequent five days, it saw a -11.66% change. Historically, PSNY's stock price tends to shift by an average of -1.86% in the 10 days leading up to earnings and 2.84% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate PSNY's annual revenue to reach 814.90M, while the EPS is projected at -3.63. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PSNY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PSNY's stock price typically moves by -1.86% in the 10 days before its earnings and 2.84% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -3.63 and revenue of 814.90M.

The earnings call presents mixed signals. While there is strong revenue growth and improvement in adjusted EBITDA, significant impairment expenses and a negative gross margin raise concerns. The Q&A section reveals proactive strategies to mitigate risks and advance technology, which adds a positive note. However, market demand declines and geopolitical uncertainties pose challenges. Given the market cap of approximately $1.7 billion, the stock is likely to experience moderate volatility, leading to a neutral prediction of -2% to 2% over the next two weeks.